Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer

Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas

(2015) Daniela Gasparotto et al.   Oncotarget

TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells

(2012) M. B. Weiss et al.   CANCER RESEARCH

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

(2012) Keun Hur et al.   GUT

Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma

(2012) Siria Lemma et al.   HISTOPATHOLOGY

Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer

(2012) Aleksandra Markiewicz et al.   Journal of Translational Medicine

New Optical Imaging Technologies for Bladder Cancer: Considerations and Perspectives

(2012) Jen-Jane Liu et al.   JOURNAL OF UROLOGY

Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities

(2012) David W. Chang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer

(2012) Bas W.G. van Rhijn   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

(2011) George J. Netto   Nature Reviews Urology

Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients

(2011) Monique M. Nijkamp et al.   RADIOTHERAPY AND ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

(2010) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Staging and Staging Errors in Bladder Cancer

(2010) Peter J. Bostrom et al.   EUROPEAN UROLOGY SUPPLEMENTS

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis

(2010) D. Xie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells

(2009) A. Ghoul et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Transurethral Resection of Non–muscle-invasive Bladder Cancer

(2009) Marko Babjuk   EUROPEAN UROLOGY SUPPLEMENTS

The morphological and molecular features of the epithelial-to-mesenchymal transition

(2009) Gema Moreno-Bueno et al.   Nature Protocols

The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers

(2009) Hervé Wallerand et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: A long-term study

(2008) Antonio S. Salinas-Sánchez et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS